reports
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Back to Near-Term Bullish on SPX and QQQ We downgraded our near-term outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ) to neutral last week (11/19/25 Compass), after being bullish since our 4/22/25 Compass, while maintaining our intermediate-term bullish outlook (as of our 5/14/25 Compass). Crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ held last week, and we are right back to being near-term bullish as long as these support levels continue to hold. Just know that SPX could see...
WAT WATERS CORPORATION
VCYT VERACYTE INC
TMO THERMO FISHER SCIENTIFIC INC.
RGEN REPLIGEN CORPORATION
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC.
IDXX IDEXX LABORATORIES INC.
HALO HALOZYME THERAPEUTICS INC.
EXEL EXELIXIS INC.
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
BRKR BRUKER CORPORATION
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ANGO ANGIODYNAMICS INC.
BIO BIO-RAD LABORATORIES INC. CLASS A
IONS IONIS PHARMACEUTICALS INC.
PKI PERKINELMER INC.
UTHR UNITED THERAPEUTICS CORPORATION
FLGT FULGENT GENETICS
MDGL MADRIGAL PHARMACEUTICALS
CELC CELCUITY
DNLI DENALI THERAPEUTICS INC
STE STERIS PLC
CSTL CASTLE BIOSCIENCES
TXG 10X GENOMICS INC CLASS A
VIR VIR BIOTECHNOLOGY
RPRX ROYALTY PHARMA PLC CLASS A
ADPT ADAPTIVE BIOTECHNOLOGIES
PRPO PRECIPIO INC.
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
6550-6569 S&P 500 Support Holding For Now After 5.5-months, the S&P 500 (SPX) has now failed to break and stay below the its 20-day MA. However, 6569 has been our level that needs to break in order for us to have confidence that a pullback has begun; SPX made a low of 6551 on Friday (less than 20 points or 0.3% from our 6569 level), meaning it was not a decisive breakdown (in time or price). As a result, our near-term bullish outlook since our 4/22/25 Compass remains intact, and it will stay t...
ILMN ILLUMINA INC.
WAT WATERS CORPORATION
TECH BIO-TECHNE CORPORATION
PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC.
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
BRKR BRUKER CORPORATION
A AGILENT TECHNOLOGIES INC.
BIO BIO-RAD LABORATORIES INC. CLASS A
PKI PERKINELMER INC.
NTLA INTELLIA THERAPEUTICS INC.
CRSP CRISPR THERAPEUTICS AG
AVTR AVANTOR INC.
PSNL PERSONALIS
TWST TWIST BIOSCIENCE
PGEN PRECIGEN INC
OGEN ORAGENICS INC.
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Revvity, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 24 June 2025 in which we reassessed the appropriateness of the ratings in the context of the ...
Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with N...
WALTHAM, Mass.--(BUSINESS WIRE)-- (NYSE: RVTY), announced today that its business has launched the (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. Now available in countries accepting the CE mark, this all-in-one solution increases the efficiency of the entire IIFT process, encompassing sample preparation, incubation, washing and mounting of slides as well as image acquisition and analysis. “Traditional IIFT processing can be tedious and time-consuming, requiring the expertise of specially trained lab technicians and a dark room,”...
Moody's says PerkinElmer, Inc.'s divestiture of its applied, food and ...
Moody's Investors Service said PerkinElmer, Inc.'s announcement that it will divest its Applied, Food and Enterprise Services businesses to private equity firm New Mountain Capital, for a total consideration of $2.45 billion in cash, has no impact on the company's Baa3 senior unsecured rating and st...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TMUS T-MOBILE US INC.
UNH UNITEDHEALTH GROUP INCORPORATED
TBI TRUEBLUE INC.
STRL STERLING CONSTRUCTION COMPANY INC.
PG PROCTER & GAMBLE COMPANY
PBH PRESTIGE CONSUMER HEALTHCARE INC
LXU LSB INDUSTRIES INC.
HSY HERSHEY COMPANY
DISCA DISCOVERY INC. CLASS A
CNC CENTENE CORPORATION
CHKP CHECK POINT SOFTWARE TECHNOLOGIES LTD.
BDX BECTON DICKINSON AND COMPANY
ATI ALLEGHENY TECHNOLOGIES INCORPORATED
SKY SKYLINE CHAMPION CORPORATION
SAFT SAFETY INSURANCE GROUP INC.
MCK MCKESSON CORPORATION
EXC EXCEET GROUP SE
BSET BASSETT FURNITURE INDUSTRIES INC.
ET ENERGY TRANSFER L.P.
NRP NATURAL RESOURCE PARTNERS L.P.
PKI PERKINELMER INC.
SXC SUNCOKE ENERGY INC.
THG HANOVER INSURANCE GROUP INC.
PBT PERMIAN BASIN ROYALTY TRUST
AA ALCOA CORPORATION
HWKN HAWKINS INC.
METC RAMACO RESOURCES
OTCM OTC MARKETS GROUP CL A
DLX DELUXE CORPORATION
ABBV ABBVIE INC.
MGY MAGNOLIA OIL & GAS CORP. CLASS A
LEGH LEGACY HOUSING CORP
PCB PCB BANCORP
REEMF RARE ELEMENT RESOURCES
BCML BAYCOM
HBT HBT FINANCIAL
PRT PERMROCK ROYALTY TRUST
BATL BATTALION OIL CORPORATION
FET FORUM ENERGY TECHNOLOGIES
AMR ALPHA METALLURGICAL RESOURCES INC
RYLB75 ROYAL BANK OF CANADA
RGC REGENCELL BIOSCIENCE HLDGS LTD
An unfavourable environment weighs on PERKINELMER, which sees a downgr...
The independent financial analyst theScreener just requalified the general evaluation of PERKINELMER (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date January 14, 2022, the ...
PerkinElmer Releases 2021 Corporate Social Responsibility Report
WALTHAM, Mass.--(BUSINESS WIRE)-- (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest achievements of its environmental, social and governance (ESG) program. The report titled, “,” also outlines four new ESG commitments unveiled by the Company earlier this year and describes its reporting framework established in accordance with guidelines from The Sustainability Accounting Standards Board (SASB). PerkinElmer’s 2021 CSR Report is organized by the three pillars of its ESG strategy – Go...
PerkinElmer Receives FDA Emergency Use Authorization for Respiratory S...
WALTHAM, Mass.--(BUSINESS WIRE)-- (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the assay. Qualified laboratories can immediately begin using this single test for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) isolated from nasopharyngeal swabs, anterior nasal swabs and mid-turbinate swabs. COVID-19, flu and RSV infections are highly contagious and often cannot be differentiated based on symptoms alone. The U.S. Centers for...
Moody's assigns Baa3 rating to PerkinElmer's notes offering
Rating Action: Moody's assigns Baa3 rating to PerkinElmer's notes offering. Global Credit Research- 08 Sep 2021. New York, September 08, 2021-- Moody's Investors Service assigned a Baa3 rating to the proposed offering of $2.3 billion senior unsecured multi-tranche notes of PerkinElmer, Inc..
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.